Profile data is unavailable for this security.
About the company
Endymed Ltd, formerly Applisonix Ltd, is an Israel-based company. The Company operated for two years under the Ma’ayan Technology Incubator Group, an investment group for high technology premature companies. The Company has three wholly-owned subsidiaries, two in Israel and one subsidiary in Hong Kong. The Company, through wholly-owned subsidiary CureLight Medical Ltd, develops, manufactures and markets ultrasound hair removal equipment based on an in-house technology for both professionals and home users. Starting from January 2012, through wholly owned subsidiary EndyMed Medical Ltd, the Company is also engaged in design, development and marketing of aesthetic treatment equipment based on radiofrequency technology, which is a solution for fractional skin resurfacing, wrinkle treatment, skin tightening, scar treatment and body contouring.
- Revenue in ILS (TTM)84.40m
- Net income in ILS2.05m
- Incorporated2004
- Employees46.00
- LocationEndymed Ltd12 LESHEM, EZOR TA'ASIYA TSFONICAESAREA 3088900IsraelISR
- Phone+972 46309100
- Fax+972 46309101
- Websitehttps://endymed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sonovia Ltd | 0.00 | -26.98m | 11.61m | 44.00 | -- | 0.3559 | -- | -- | -1.67 | -1.50 | 0.00 | 1.98 | 0.00 | -- | -- | 0.00 | -55.93 | -- | -62.66 | -- | -- | -- | -- | -- | -- | -13.62 | 0.0054 | -- | -- | -- | -187.75 | -- | 77.26 | -- |
| Elbit Medical Technologies Ltd | 1.29m | -65.93m | 11.77m | 232.00 | -- | 0.44 | -- | 9.13 | -0.7346 | -0.7346 | 0.0147 | 0.2948 | 0.0211 | -- | 38.67 | -- | -108.02 | 37.04 | -110.43 | 38.19 | -- | -- | -5,113.22 | 41.14 | -- | -0.011 | 0.00 | -- | 314.29 | -55.19 | -248.15 | -- | -- | -- |
| Human Xtensions Ltd | 4.95m | -36.64m | 12.04m | 50.00 | -- | 0.4612 | -- | 2.43 | -1.37 | -1.37 | 0.185 | 0.9757 | 0.0922 | 0.4634 | 2.21 | 99,000.00 | -68.25 | -49.34 | -77.27 | -55.69 | 51.66 | 49.34 | -740.10 | -485.43 | 4.75 | -- | 0.0608 | -- | 56.00 | -- | 17.84 | -- | -19.95 | -- |
| BioLight Life Sciences Ltd | 118.00k | -26.02m | 17.56m | 4.00 | -- | 0.5899 | -- | 148.85 | -5.60 | -5.60 | 0.0255 | 6.39 | 0.0026 | -- | 0.2903 | 29,500.00 | -60.77 | -20.22 | -65.01 | -21.13 | -- | -- | -23,294.07 | -12,746.09 | -- | -0.6326 | 0.003 | -- | 87.30 | -49.76 | -231.59 | -- | 92.16 | -- |
| Allmed Solutions Ltd | 0.00 | 1.42m | 38.65m | 19.00 | 21.85 | 0.8063 | 20.36 | -- | 0.0182 | 0.0182 | 0.00 | 0.4924 | 0.00 | -- | -- | 0.00 | 2.43 | 1.43 | 2.68 | 1.59 | -- | 50.43 | -- | 15.58 | -- | -- | 0.0154 | -- | -- | -- | 111.71 | -- | -10.48 | -- |
| Erika B-Cure Laser Ltd | 37.07m | -27.96m | 42.71m | -- | -- | 1.29 | -- | 1.15 | -0.2685 | -0.2685 | 0.356 | 0.3169 | 0.5125 | 0.4923 | 2.81 | -- | -38.66 | -- | -50.00 | -- | 82.68 | -- | -75.43 | -- | 2.10 | -28.67 | 0.1568 | -- | -53.09 | -- | -354.15 | -- | -- | -- |
| Endymed Ltd | 84.40m | 2.05m | 46.03m | 46.00 | 21.93 | 0.8134 | 12.43 | 0.5453 | 0.1525 | 0.1525 | 6.20 | 4.11 | 1.13 | 2.46 | 18.63 | 1,834,799.00 | 2.75 | 10.38 | 3.38 | 13.32 | 51.20 | 51.92 | 2.43 | 8.91 | 3.02 | -- | 0.0771 | -- | 6.77 | 4.30 | -34.94 | -22.83 | -15.24 | -- |
| Epitomee Medical Ltd | 37.05m | -21.05m | 91.06m | 42.00 | -- | 0.7062 | -- | 2.46 | -0.7112 | -0.7112 | 1.25 | 4.33 | 0.2095 | -- | 35.21 | 882,190.50 | -11.90 | -- | -12.44 | -- | -- | -- | -56.82 | -- | -- | -- | 0.1021 | -- | -- | -- | 63.08 | -- | -- | -- |
| Nissan Medical Industries Ltd. | 733.91m | 5.65m | 127.99m | 395.00 | 23.84 | 0.5597 | 2.55 | 0.1744 | 0.5911 | 0.5911 | 79.17 | 25.18 | 1.02 | 5.40 | 6.92 | 1,858,010.00 | 2.64 | 4.12 | 5.01 | 7.71 | 18.50 | 18.76 | 2.59 | 4.32 | 0.6375 | 1.83 | 0.3585 | -- | 7.20 | 2.20 | 115.67 | -25.79 | -3.21 | -- |
| Pulsenmore Ltd | 6.19m | -58.57m | 167.52m | 76.00 | -- | 1.27 | -- | 27.07 | -1.14 | -1.14 | 0.1208 | 2.64 | 0.0297 | 0.2102 | 2.26 | 81,421.05 | -28.14 | -- | -30.33 | -- | 35.57 | -- | -946.46 | -- | 10.00 | -19.48 | 0.1734 | -- | -42.78 | -- | -164.78 | -- | -- | -- |
| Bonus Biogroup Ltd | 0.00 | -28.53m | 193.88m | 58.00 | -- | 6.62 | -- | -- | -0.064 | -0.064 | 0.00 | 0.0251 | 0.00 | -- | -- | 0.00 | -47.75 | -76.10 | -53.85 | -97.19 | -- | -- | -- | -- | -- | -- | 0.2758 | -- | -- | -- | 26.29 | -- | 19.30 | -- |
Data as of May 02 2024. Currency figures normalised to Endymed Ltd's reporting currency: Israeli Shekel ILS
1.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sigma Mutual Funds Ltd.as of 29 Feb 2024 | 136.23k | 0.99% |
| Psagot Mutual Funds Ltd.as of 31 Dec 2023 | 31.13k | 0.23% |
| Sigma PCM Mutual Funds Management Co. Ltd.as of 29 Feb 2024 | 14.39k | 0.11% |
| Ayalon Financial Solutions (2004) Ltd.as of 28 Dec 2023 | 5.76k | 0.04% |
| Lamashkia Mutual Funds Management Co. (1982) Ltd.as of 28 Dec 2023 | 137.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
